Literature DB >> 11512082

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease.

R A Kalish1, G McHugh, J Granquist, B Shea, R Ruthazer, A C Steere.   

Abstract

The interpretation of serological results for patients who had Lyme disease many years ago is not well defined. We studied the serological status of 79 patients who had had Lyme disease 10-20 years ago and did not currently have signs or symptoms of active Lyme disease. Of the 40 patients who had had early Lyme disease alone, 4 (10%) currently had IgM responses to Borrelia burgdorferi, and 10 (25%) still had IgG reactivity to the spirochete, as determined by a 2-test approach (enzyme-linked immunosorbent assay and Western blot). Of the 39 patients who had had Lyme arthritis, 6 (15%) currently had IgM responses and 24 (62%) still had IgG reactivity to the spirochete. IgM or IgG antibody responses to B. burgdorferi may persist for 10-20 years, but these responses are not indicative of active infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11512082     DOI: 10.1086/322669

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  87 in total

Review 1.  The emergence of Lyme disease.

Authors:  Allen C Steere; Jenifer Coburn; Lisa Glickstein
Journal:  J Clin Invest       Date:  2004-04       Impact factor: 14.808

2.  Performance of a Modified Two-Tiered Testing Enzyme Immunoassay Algorithm for Serologic Diagnosis of Lyme Disease in Nova Scotia.

Authors:  Ian R C Davis; Shelly A McNeil; Wanda Allen; Donna MacKinnon-Cameron; L Robbin Lindsay; Katarina Bernat; Antonia Dibernardo; Jason J LeBlanc; Todd F Hatchette
Journal:  J Clin Microbiol       Date:  2020-06-24       Impact factor: 5.948

3.  Evaluation of the C6 Lyme Enzyme Immunoassay for the Diagnosis of Lyme Disease in Children and Adolescents.

Authors:  Susan C Lipsett; John A Branda; Alexander J McAdam; Louis Vernacchio; Caroline D Gordon; Catherine R Gordon; Lise E Nigrovic
Journal:  Clin Infect Dis       Date:  2016-06-28       Impact factor: 9.079

4.  Autoimmune Arthritides, Rheumatoid Arthritis, Psoriatic Arthritis, or Peripheral Spondyloarthritis Following Lyme Disease.

Authors:  Sheila L Arvikar; Jameson T Crowley; Katherine B Sulka; Allen C Steere
Journal:  Arthritis Rheumatol       Date:  2017-01       Impact factor: 10.995

5.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

6.  Clinical pearls in infectious diseases.

Authors:  Randall S Edson; John B Bundrick; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2011-03       Impact factor: 7.616

Review 7.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

8.  Evaluation of the Modified Two-Tiered Testing Method for Diagnosis of Lyme Disease in Children.

Authors:  Susan C Lipsett; John A Branda; Lise E Nigrovic
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

9.  [Cutaneous manifestations of Lyme disease : Pitfalls in the serological diagnostic workup].

Authors:  M Glatz; R R Müllegger
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

10.  Evaluation of Modified 2-Tiered Serodiagnostic Testing Algorithms for Early Lyme Disease.

Authors:  John A Branda; Klemen Strle; Lise E Nigrovic; Paul M Lantos; Timothy J Lepore; Nitin S Damle; Mary Jane Ferraro; Allen C Steere
Journal:  Clin Infect Dis       Date:  2017-04-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.